"Preventative chemotherapy" is not a commonly-used term in medicine, though the World Health Organization does utilize the term. However, the WHO's primary explanation of its use is in the treatment ...

In March 2024, Catherine, the Princess of Wales, announced her cancer diagnosis. The 42-year-old did not reveal the type of cancer she was facing but shared that she had undergone major abdominal ...

Depending on the disease specifics, patients with melanoma may undergo pre- or post-surgical therapies. Skin melanoma, one of the most serious forms of skin cancer, poses a significant threat to ...

The lidERA Breast Cancer study is a phase 3, randomized, open-label trial testing whether the adjuvant therapy giredestrant ...

Roche claimed the results make its drug giredestrant the first of its kind, a so-called oral SERD, to show a benefit in the ...

Roche has reported another phase 3 win for its oral selective estrogen receptor degrader (SERD). Success at a planned interim ...

Regeneron Pharmaceuticals’ Libtayo (cemiplimab) has received approval from the European Commission for the adjuvant treatment ...

Roche's oral selective oestrogen receptor degrader (SERD) giredestrant has achieved what the company says is a stellar result ...

A Markov chain model evaluated the cost-effectiveness of abemaciclib and ribociclib with letrozole compared with letrozole alone for HR+/HER2– EBC from a payer perspective in India. Key measures ...

The exercise prescriptions also prevented other new cancers, like breast and prostate cancer. Many included just three to four brisk walks each week.

The odds of cancer returning, known as risk of recurrence, depends on several factors, including tumor type, stage, and size; ...

As part of the OneOncology Network, CCBD continues to lead nationally in expanding value-based, community-driven cancer care. The addition of Adjuvant's behavioral health expertise represents a shared ...